Drug
Ado-trastuzumab Emtansine Regimen
CI-DRUG-00000041Explore in graph →NCIt C159982 CIViC
Regulatory
Approvals (0)
Each record names the authority, jurisdiction, indication text and status. A drug approved in one jurisdiction for one indication is not 'approved' in general.
Data not yet available
No regulatory approval recorded. Absence here is not evidence of absence: only ingested jurisdictions are covered.
What CancerIndex knows
Derived
Development pipeline
Most advanced stage across all cancers, then per top-level cancer reached through trial conditions or approval indications. Approval in any ingested jurisdiction outranks trial phase; counts are interventional studies.
Data not yet available
No registered interventional trial or approval record places this drug in the pipeline yet.
Curated evidence
Clinical evidence (1)
CIViC items in which this therapy appears, grouped by cancer context, then molecular profile. 50 items per page.
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 29989854
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| ERBB2 A775_G776insIVMA + ERBB2 A775_G776insYVMA + ERBB2 Amplification + ERBB2 G776delinsVC + ERBB2 G776_V777>VCV + ERBB2 G778-779 insCPG + ERBB2 G778_P780dup + ERBB2 L755P + ERBB2 S310F + ERBB2 S335C + ERBB2 V659E | ||||||||
Clinical trials
Trials with this intervention (0)
Data not yet available
No registered study lists this drug as an intervention yet.